This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Vishal Toprani
Scientist, Pharmaceutical Development at Alexion


Dr. Vishal Toprani is a Scientist in the Pharmaceutical Development department at Alexion Pharmaceuticals, New Haven, CT. Dr. Toprani received his Ph.D. in pharmaceutical chemistry from Macromolecule and Vaccine Stabilization Center (Drs. David Volkin and Russ Middaugh’s laboratory) at University of Kansas in which his doctoral studies was focused on better understanding of vaccine stability as applied to pharmaceutical development of various recombinant protein vaccine candidates. After his Ph.D he subsequently started as a scientist at Alexion Pharmaceuticals. He is currently focused on stabilizing and formulating high concentration antibody drug products using state-of-the-art biophysical technologies and modern high throughput approaches.